These GFAP.tTA.TRE.Flag.HMOX1 mice express human heme oxygenase 1 (HMOX1) in astrocytes under the control of the Tet-Off system (removal of doxycycline from diet initiates transgene expression), resulting in 1.4 to 5.8-fold increase in total of heme oxygenase 1 protein in astrocytes. Depending on the window of gene expression, these double transgenic mice exhibit inducible locomotor impairment, stereotypy, and mitochondrial damage & autophagy. They are suitable for use in applications related to the study of oxidative stress in the brain, neurodevelopment and neurodegenerative diseases.
Hyman Schipper, McGill University
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Inducible, Inserted expressed sequence, Humanized sequence) |
Allele Type |
---|
Transgenic (Transactivator) |
Heme oxygenase 1, encoded by the HMOX1 gene, is an oxidative stress-response enzyme that is involved in heme catabolism: degradation of cellular heme to biliverdin/bilirubin, free iron, and CO. Up-regulated in the brains of patients with Alzheimer’s disease and Parkinson’s disease, heme oxygenase 1 also exhibits anti-tumor, anti-inflammatory, anti-oxidant, and anti-proliferative activity.
These GFAP.tTA.TRE.Flag.HMOX1 mice express human heme oxygenase 1 (HMOX1) in astrocytes under the control of the Tet-Off system. Transgene expression, induced by removal of doxycycline from the diet, is detected in CNS astrocytes, ependymocytes, and ependymal tanycytes. Immunohistochemical examination reveals no transgene expression in oligodendroglia, microglia, neurons, cerebrovascular cells. No transgene expression is observed in heart, liver, spleen, lung, kidney, stomach, intestines, or gonads. In 48 week old mice, doxycycline treatment inhibited transgene expression, as detected by RT-PCR analysis, of striatum and substantia nigra/ ventral tegmental area.
Phenotype description of induced transgenic mice (doxycycline removed from diet):
48 week old male transgenic mice, under continuous induction conditions starting from embryogenesis, exhibit impaired prepulse inhibition, and both male and female transgenic mice at 6.5 months of age exhibit hyperlocomotor activity, increased dopamine and 5-hydroxytryptamine (5-HT)/ 5-hydroxyindoleacetic acid (5-HIAA) levels, decreased neuronal reelin levels and abnormal hippocampal morphology. At this age point, the transgenic mice exhibit a phenotype with characteristics similar to human schizophrenia.
By shifting the window of transgene expression to mid-to-late life, between 8.5 and 19 months of age transgenic mice exhibit a phenotype with behavioral, pathological, neurochemical and gene expression profiles that are similar to features of human Parkinson's disease.
At this age, the transgenic mice exhibit locomotor incoordination, stereotypy, and increased alpha-synuclein and ubiquitin levels in the striatum and substantia nigra.
At 19 months of age, transgenic mice develop corpora amylacea, glycoproteinaceous inclusions (predominantly glial and extracellular).
Male transgenic mice exhibit a 1.4 to 5.8-fold increase in total heme oxygenase 1 protein levels in the brain when compared to wildtype controls, with the highest expression level in the substantia nigra/ ventral tegmental area. Ferric iron deposits are increased in the astrocytes of substantia nigra.
Ultrastructural examination of astrocytes from the amygdala and substantia nigra shows fewer mitochondria that are disorganized, dysmorphic and often swollen, as well as degraded “myelin figure” membranes in neurites near abnormal astrocytes.
While scant or no iron is detected in wildtype astroctyes (cytoplasm or organelles) by dynamic secondary ion mass spectrometry analysis, iron is detected in dysmorphic organelles and autophagic cytoplastic bodies of astrocytes from transgenic animals.
In a model of in situ parenchymal hemorrhage, injection of collagenase into the striata of transgenic mice results in approximately 4.5% mortality compared to the approximately 23% mortality rate of wildtype controls.
The Donating Investigator reports that there is no major phenotype difference between transgenic mice hemizygous or homozygous for the transgenes.
Mice that are homozygous for the transgenes are viable and fertile.
The pGFAP.tTA transgenic construct containing the tetracycline transcriptional activator (tTA) under the control of the human glial fibrillary acidic protein (GFAP), was injected into fertilized FVB mouse eggs. Founder line 6 was subsequently established.
The pTRE2.Flag.HMOX1 transgenic construct containing flag tagged human heme oxygenase 1 (HMOX1) under the control of the tetO, tetracycline-responsive regulatory element, and CMV promoter/enhancer, was injected into fertilized FVB mouse eggs. Founder line 6 was subsequently established.
The 2 transgenic lines were intercrossed to generate GFAP.tTA.TRE.Flag.HMOX1 animals.
The double transgenic mice were maintained on the FVB background. Upon arrival, sperm was cryopreserved. To establish our live colony, an aliquot of frozen sperm was used to fertilize FVB/NJ oocytes (Stock No. 001800) at least once to establish the colony. Embryos were later cryopreserved.
Expressed Gene | HMOX1, heme oxygenase 1, human |
---|---|
Expressed Gene | FLAG, FLAG octapeptide, |
Site of Expression | CNS astrocytes, ependymocytes, and ependymal tanycytes. |
Expressed Gene | tTA, tetracycline-controlled transactivator, E. coli |
Site of Expression | Human heme oxygenase 1 (HMOX1) is expressed in in astrocytes. |
Allele Name | transgene insertion 6, Hyman M Schipper |
---|---|
Allele Type | Transgenic (Inducible, Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | TRE2.Flag.HMOX1 |
Gene Symbol and Name | Tg(tetO-HMOX1)6Hyms, transgene insertion 6, Hyman M Schipper |
Gene Synonym(s) | |
Promoter | tetO, tet operator, |
Expressed Gene | HMOX1, heme oxygenase 1, human |
Expressed Gene | FLAG, FLAG octapeptide, |
Site of Expression | CNS astrocytes, ependymocytes, and ependymal tanycytes. |
Strain of Origin | FVB/N |
Chromosome | UN |
Molecular Note | The tetracycline-responsive element and the minimal human cytomegalovirus (CMV) promoter drive the expression of a FLAG-tagged human HMOX1 coding sequence. The pound symbol (#) is used when line is not specified and/or lines are pooled. |
Allele Name | transgene insertion 6, Hyman M Schipper |
---|---|
Allele Type | Transgenic (Transactivator) |
Allele Synonym(s) | GFAP.tTA |
Gene Symbol and Name | Tg(GFAP-tTA)6Hyms, transgene insertion 6, Hyman M Schipper |
Gene Synonym(s) | |
Promoter | GFAP, glial fibrillary acidic protein, human |
Expressed Gene | tTA, tetracycline-controlled transactivator, E. coli |
Site of Expression | Human heme oxygenase 1 (HMOX1) is expressed in in astrocytes. |
Strain of Origin | FVB/N |
Chromosome | UN |
Molecular Note | Expression of the tetracycline transactivator protein (containing the wild-type VP16 domain which allows for high tTA expression) is under the control of the glial fibrillary acidic protein promoter. |
When maintaining a live colony, mice hemizygous or homozygous for both transgenes may be bred to each other, to wildtype siblings, or to FVB/NJ inbred mice (Stock No. 001800).
When using the GFAP.HMOX1 mouse strain in a publication, please cite the originating article(s) and include JAX stock #031671 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or non carrier for Tg(GFAP-tTA)6Hyms, Hemizygous or non carrier for Tg(tetO-HMOX1)6Hyms |
Frozen Mouse Embryo | FVB/N-Tg(GFAP-tTA)6Hyms Tg(tetO-HMOX1)6Hyms/J | $2595.00 |
Frozen Mouse Embryo | FVB/N-Tg(GFAP-tTA)6Hyms Tg(tetO-HMOX1)6Hyms/J | $2595.00 |
Frozen Mouse Embryo | FVB/N-Tg(GFAP-tTA)6Hyms Tg(tetO-HMOX1)6Hyms/J | $3373.50 |
Frozen Mouse Embryo | FVB/N-Tg(GFAP-tTA)6Hyms Tg(tetO-HMOX1)6Hyms/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.